Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34042250)
Watch
English
Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML
scientific article
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25294819
retrieved
30 July 2017
title
Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25294819
retrieved
30 July 2017
main subject
ibrutinib
1 reference
based on heuristic
inferred from title
author
David J MacEwan
series ordinal
5
1 reference
stated in
Europe PubMed Central
PMC publication ID
4259448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25294819%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
Kristian Bowles
series ordinal
6
1 reference
stated in
Europe PubMed Central
PMC publication ID
4259448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25294819%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
Stuart A Rushworth
series ordinal
7
1 reference
stated in
Europe PubMed Central
PMC publication ID
4259448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25294819%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
author name string
Lyubov Zaitseva
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
4259448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25294819%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
Megan Y Murray
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
4259448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25294819%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
Manar S Shafat
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
4259448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25294819%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
Matthew J Lawes
series ordinal
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
4259448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25294819%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
language of work or name
English
0 references
publication date
1 October 2014
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25294819
retrieved
30 July 2017
published in
Oncotarget
1 reference
stated in
Europe PubMed Central
PMC publication ID
4259448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25294819%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
volume
5
1 reference
stated in
Europe PubMed Central
PMC publication ID
4259448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25294819%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
issue
20
1 reference
stated in
Europe PubMed Central
PMC publication ID
4259448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25294819%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
page(s)
9930-9938
1 reference
stated in
Europe PubMed Central
PMC publication ID
4259448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25294819%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
cites work
Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
MyD88 is involved in myeloid as well as lymphoid hematopoiesis independent of the presence of a pathogen
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Nurture versus nature: the microenvironment in chronic lymphocytic leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Survey of activated FLT3 signaling in leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanism
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
HO-1 underlies resistance of AML cells to TNF-induced apoptosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Btk is required for an efficient response to erythropoietin and for SCF-controlled protection against TRAIL in erythroid progenitors.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Pertussis toxin and target eukaryotic cells: binding, entry, and activation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
5 July 2018
Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemia.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
28 October 2018
Bruton's tyrosine kinase: oncotarget in myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
28 October 2018
Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
28 October 2018
Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
28 October 2018
Bruton's Tyrosine Kinase and Phospholipase Cγ2 Mediate Chemokine-Controlled B Cell Migration and Homing
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4259448
retrieved
28 October 2018
Ibrutinib in relapsed chronic lymphocytic leukemia
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/25294819
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.18632/ONCOTARGET.2479
1 reference
stated in
Europe PubMed Central
PMC publication ID
4259448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25294819%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
PMC publication ID
4259448
1 reference
stated in
Europe PubMed Central
PMC publication ID
4259448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25294819%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
PubMed publication ID
25294819
1 reference
stated in
Europe PubMed Central
PMC publication ID
4259448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25294819%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
ResearchGate publication ID
266627187
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit